David Corliss says statisticians can help address the distrust of vaccines, a large challenge of this phase of the COVID-19 pandemic.
biopharmaceutical
Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials
The editorial team invited authors from government, industry, and academia to write articles about their perspectives on the impact of COVID-19 on clinical trials, particularly the statistical issues involved in designing new COVID-19 trials.
Sisters Collaborate on Book for Students Interested in Pharmaceutical Industry
ASA members and sisters Olga V. Marchenko and Natallia V. Katenka answer questions about the book they co-edited, Quantitative Methods in Pharmaceutical Research and Development: Concepts and Application.
Pharma Executive Offers Thoughts About COVID-19
Dr. Amrit Ray, global president, R&D and Medical, Upjohn Division, Pfizer Inc., offers his thoughts about the COVID-19 pandemic and how to best protect yourself and your family.
Biopharmaceutical Section Offers Advice for ASA Fellow Nomination
Biopharmaceutical Section members discuss their experiences as ASA Fellow nominees, describe what they learned while nominating others, and share advice for those considering nomination.
Biopharmaceutical Section Invites Members to Join Mentoring Program
The goal of the program is to help members further enrich and enhance their professional experience through achieving personal and professional goals.
John Peterson Receives Award for Bayesian Approach
John Peterson, senior director in chemistry and manufacturing control statistics at GlaxoSmithKline Pharmaceuticals, was recently presented with the 2019 AIChE Pharmaceutical Discovery, Development, and Manufacturing Award.
ASA to Cosponsor AI in Clinical Drug Development Symposium in May
The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.
Biopharmaceutical Applied Statistics Symposium
The 26th meeting of the Biopharmaceutical Applied Statistics Symposium (BASS XXVI) will be held October 21–24, 2019.
Using Big Data in Precision Medicine
Experts from pharma, biotech, government, academia, and technology providers discuss the opportunity to use big data to find the right drug at the right time using the right target.